In contrast to the severe lethargic pathology in Mfp2−/− mice, Nestin-Mfp2−/− mice develop a milder clinical decline dominated by ataxia at a preterminal stage of disease (Verheijden et al., 2013, 2014). The gene discussed is HSD17B4; the disease is cerebellar ataxia.